Skip to main content
    P

    Privia Health Group Inc (PRVA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $24.42
    +0.48 (+2.00%)

    Market Cap: $2.86B

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    79%(19/24)
    Avg Surprise
    +34.14%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.15
    Range$0.04 - $0.51
    10 analysts
    Revenue Consensus
    $685M
    Range$644M - $750M
    14 analysts
    Last 12 of 24 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.15$0.04 - $0.51--10--
    Sep 26
    Reported Nov 5
    		$0.10$0.09-+11.11%Beat10
    5
    4
    30d
    		-65.5%
    Jun 26
    Reported Aug 6
    		$0.07$0.08--12.50%Miss11
    2
    7
    30d
    		+250.0%
    Mar 26
    Reported May 7
    		$0.19$0.25$0.19 - $0.28-24.00%Miss11
    1
    1
    30d
    		-13.6%
    Dec 25
    Reported Feb 26
    		$0.07$0.04-+75.00%Beat12
    1
    1
    30d
    		-66.7%
    Sep 25
    Reported Nov 6
    		$0.29$0.22$0.17 - $0.24+31.82%Beat10
    2
    1
    30d
    		+45.0%
    Jun 25
    Reported Aug 7
    		$0.02N/A--60.00%Miss12
    3
    4
    30d
    		-89.5%
    Mar 25
    Reported May 8
    		$0.22$0.18$0.12 - $0.22+22.22%Beat12
    3
    4
    30d
    		+22.2%
    Dec 24
    Reported Feb 27
    		$0.21$0.20$0.15 - $0.22+4.58%Beat12
    0
    1
    30d
    		+950.0%
    Sep 24
    Reported Nov 7
    		$0.20$0.20$0.18 - $0.22+0.00%Beat15
    0
    1
    30d
    		+17.6%
    Jun 24
    Reported Aug 8
    		$0.19$0.18$0.14 - $0.21+5.56%Beat13
    1
    1
    30d
    		+11.8%
    Mar 24
    Reported May 9
    		$0.18$0.15$0.13 - $0.17+20.00%Beat14
    1
    0
    30d
    		+12.5%
    Dec 23
    Reported Feb 27
    		$0.02$0.04$0.00 - $0.07-50.00%Miss13
    0
    2
    30d
    		-85.7%

    Key Metrics

    Valuation
    P/E Ratio56.79EV/EBITDA37.53x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin1.19%Operating Margin1.86%
    ROE4.31%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.63xQuick Ratio1.63x
    Trading Statistics
    Beta0.75Avg Volume1.38M
    52-Week High$28.8252-Week Low$18.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.28
    SMA 20$22.29
    SMA 50$21.04
    SMA 200$22.65
    EMA 10$22.65
    EMA 20$22.16
    EMA 50$21.78
    EMA 200$22.49

    MACD

    Line: 0.55Signal: 0.38Hist: 0.16

    ADX

    ADX: 25.4+DI: 35.1-DI: 16.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$20.91

    Bollinger Bands

    Upper Band$23.92
    Lower Band$20.66
    %B Position1463%(Upper)
    Band Width1.15

    RSI (14-Day)

    Overbought
    72.6

    Momentum Oscillators

    Stoch %K89.1
    Stoch %D65.4
    Williams %R-0.8
    ROC (10d)9.0%
    Momentum2.01
    CCI (20d)227.3
    MFI (14d)68.6

    Volatility Measures

    ATR (14d)$0.76(3.1%)
    StdDev (20d)0.82
    Hist Vol38.7%(Moderate)

    Volume Flow

    VWAP$24.18
    OBV628.9K
    AD Line-4.8M
    CMF (20d)0.157

    Volume Metrics

    Avg Vol (20d)1.4M
    Vol Ratio2.0x(High)
    VWMA (20d)$22.54

    Pivot Points

    R3$26.05
    R2$25.01
    R1$24.48
    Pivot Point$23.44
    S1$22.91
    S2$21.87
    S3$21.34

    Advanced Oscillators

    TSI23.57
    Ultimate Osc61.6
    KST88.03

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$656.96M$632.63M$603.85M$541.17M$580.42M$521.15M$480.10M$460.90M$437.92M$422.33M$415.24M$440.83M
    Cost of Revenue$69.67M$69.36M$68.42M$66.85M$61.44M$64.92M$59.53M$59.77M$56.07M$57.11M$54.06M$52.41M
    Gross Profit$587.29M$563.27M$535.43M$474.32M$518.98M$456.24M$420.57M$401.13M$381.85M$365.22M$361.19M$388.42M
    Operating Expenses$566.75M$551.50M$528.00M$463.05M$504.58M$452.90M$415.35M$395.88M$376.04M$360.12M$360.36M$387.00M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$34.45M$39.66M$41.47M$29.27M$39.64M$37.52M$31.72M$34.42M$30.70M$28.92M$32.12M$29.60M
    Operating Income$20.54M$11.77M$7.42M$11.28M$14.40M$3.34M$5.22M$5.25M$5.81M$5.10M$823,000$1.42M
    Interest Income$1.72M$1.67M$0$0$2.27M$2.41M$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$22.27M$16.75M$9.31M$13.37M$16.67M$5.74M$8.15M$8.02M$7.98M$8.06M$3.81M$4.27M
    Income Tax Expense$7.67M$7.02M$5.60M$2.79M$6.87M$2.46M$2.10M$2.65M$4.00M$3.42M$751,000$1.94M
    Net Income$14.59M$9.73M$3.71M$10.59M$9.81M$3.29M$6.05M$5.37M$3.98M$4.64M$3.06M$2.32M
    EBITDA$24.04M$18.44M$12.59M$16.03M$17.17M$5.92M$10.05M$9.85M$9.77M$9.88M$5.63M$3.19M
    EBIT$20.54M$15.08M$9.31M$13.37M$14.40M$3.34M$8.15M$8.02M$7.98M$8.06M$3.81M$1.42M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRVA

    News

    Privia Health Raises 2026 Outlook as Adjusted EBITDA Grows 21.9%

    Privia Health (Nasdaq: PRVA) has raised its full-year 2026 outlook following a 21.9% increase in nine-month adjusted EBITDA, driven by significant growth in providers, attributed lives...

    TradingKey•11/5/26•Bullish

    Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results

    Privia Health (Nasdaq: PRVA) reported strong third-quarter 2026 results with revenue up 13.2% to $657.0 million and net income attributable to Privia increasing 96.6% to $13.5 million. The company raised its full-year...

    Stock Titan•11/5/26•Bullish

    Privia Health Raises 2026 Revenue Guidance to $2.55B

    Privia Health reported a strong third-quarter 2026 with revenue increasing 13.2% to $657 million and net income soaring 96.6% to $13.5 million. Following this performance...

    grafa.com•11/5/26•Bullish

    Privia Health Group earnings beat by $0.12, revenue topped estimates

    Privia Health Group (NASDAQ: PRVA) reported strong third-quarter results, with EPS of $0.21, significantly surpassing analyst estimates of $0.09. The company also exceeded revenue expectations...

    Investing.com•11/5/26•Bullish

    Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 12c ; Offers Guidance

    Privia Health Group, Inc. (PRVA) reported strong third-quarter results, surpassing analyst estimates with an EPS of $0.21, significantly higher than the projected $0.09. The company also exceeded revenue expectations...

    StreetInsider•11/5/26•Bullish

    PRVA Valuation and Fair Value

    P/E
    56.8x
    Forward P/E
    19.4x
    EV/EBITDA
    37.5x
    P/B
    3.8x
    See GNG's fair value

    PRVA Profitability: Margins, ROIC and FCF

    Gross margin
    88.7%
    Operating margin
    1.9%
    Net margin
    1.2%
    ROE
    4.3%
    FCF margin
    4.4%

    PRVA Competitors

    CompanyTicker
    Beam Therapeutics IncBEAM
    Zai Lab LtdZLAB
    Ideaya Biosciences IncIDYA
    Soleno Therapeutics IncSLNO
    Bausch Health Companies IncBHC
    Regencell Bioscience Holdings LtdRGC
    Aveanna Healthcare Holdings IncAVAH
    Progyny IncPGNY

    Sector: Healthcare

    PRVA Analyst Ratings

    Consensus
    Buy
    Analysts
    18
    Strong Buy
    5
    Buy
    12
    Hold
    1
    Sell
    0
    Strong Sell
    0

    PRVA Bull Case vs Bear Case

    Bull case

    • PRVA grew quarterly revenue 21.4% year over year.
    • 94.4% of PRVA's analyst ratings are Buy or Strong Buy.

    Bear case

    • PRVA trades at 56.8x trailing earnings.

    PRVA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    6.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.15

    PRVA Earnings Date

    PRVA reports Feb 24, 2027, after the close. The date is estimated.

    PRVA Earnings Call

    The latest PRVA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    PRVA ETF Holders

    GNG tracks 10 ETFs that hold PRVA. The largest weights:

    1. Fidelity Enhanced Small Cap Core ETF (FESM), 0.20% of the fund
    2. iShares Core S&P Small-Cap ETF (IJR), 0.16% of the fund
    3. iShares Russell 2000 ETF (IWM), 0.09% of the fund
    4. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.09% of the fund
    5. Vanguard Extended Market Index Fund ETF Shares (VXF), 0.08% of the fund
    Open the ETF Stock Exposure tool for PRVA

    See insider activity

    Frequently Asked Questions About PRVA

    When does PRVA report earnings?

    Privia Health Group Inc (PRVA) is expected to report earnings on Feb 24, 2027.

    Does PRVA pay dividends?

    Privia Health Group Inc (PRVA) does not currently pay a regular dividend.

    What is PRVA's P/E ratio?

    Privia Health Group Inc has a price-to-earnings (P/E) ratio of 56.79.

    What is PRVA's market cap?

    Privia Health Group Inc (PRVA) has a market capitalization of $2.86B with a current stock price of $24.42.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In